This inventor holds 1 USPTO granted patent. Top assignee: Selectx Pharmaceuticals, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Babu Rao Renikuntla: Innovator in Antibiotic Development
Introduction
Babu Rao Renikuntla is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of antibiotic research, particularly in developing new compounds to combat bacterial infections.
Latest Patents
Renikuntla holds a patent for "4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics." This innovative patent discloses aminoglycoside antibiotics that are particularly useful for treating bacterial infections, especially those resistant to known antibiotics. His work in this area is crucial for advancing medical treatments and improving patient outcomes.
Career Highlights
Babu Rao Renikuntla is associated with Selectx Pharmaceuticals, Inc., where he applies his expertise in antibiotic development. His role at the company allows him to contribute to the advancement of pharmaceutical innovations that address critical health challenges.
Collaborations
Renikuntla collaborates with esteemed colleagues, including Michael G Chaparian and Michael Brady. These partnerships enhance the research and development efforts at Selectx Pharmaceuticals, Inc., fostering a collaborative environment for innovation.
Conclusion
Babu Rao Renikuntla's work in antibiotic development exemplifies the importance of innovation in healthcare. His contributions are vital in the ongoing battle against antibiotic-resistant infections, showcasing the impact of dedicated inventors in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile